Scope and purpose To review the scientific evidence and develop clinical recommendations on professionally applied topical fluoride. Methodology Medline and the Cochrane Database of Systematic Reviews were searched for systematic reviews published in the English language that dealt with professionally applied topical fluoride, including gel, foam or varnish, at any time up to October 2005. Seventeen systematic reviews were identified. Clinical studies published after January 2004 and thus not included in the systematic reviews were also identified through Medline. The American Dental Association (ADA) Council on Scientific Affairs formed a panel of experts to evaluate the identified systematic reviews and clinical trials. The panellists were provided with the identified publications and asked to identify any additional systematic reviews or other relevant published trials. One additional publication was included that had been accepted for publication. The individual studies were assessed at a workshop and a draft document was submitted for review to scientists with expertise in fluoride and caries, relevant ADA agencies and the external reviewers. The comments received were considered by the expert panel and the clinical recommendations were approved by the ADA Council on Scientific Affairs. The evidence (Table  1) and strength of recommendations (Table 2) were graded as shown.
) and recommend planning topical fluoride applications based on an assessment of a patient's clinical risk (Table 4) : a summary of the main clinical recommendations is shown in Table 5 . The full document and an executive summary can be downloaded (www.ada.org/ prof/resources/topics/evidencebased.asp). *Factors increasing risk of developing caries also may include, but are not limited to, high titres of cariogenic bacteria, poor oral hygiene, prolonged nursing (bottle or breast), poor family dental health, developmental or acquired enamel defects, genetic abnormality of teeth, many multisurface restorations, chemotherapy or radiation therapy, eating disorders, drug or alcohol abuse, irregular dental care, cariogenic diet, active orthodontic treatment, presence of exposed root surfaces, restoration overhangs and open margins, and physical or mental disability with inability or unavailability of performing proper oral health care. † On the basis of findings from population studies, groups with low socio-economic status have been found to have an increased risk of developing caries. In children too young for their risk to be based on caries history, low socio-economic status should be considered as a caries risk factor. ‡ Medication-, radiation-or disease-induced xerostomia. 
Commentary
The ADA have been increasingly active in supporting evidence-based dentistry since developing a definition and policy for this approach to practice. This, their first evidence-based clinical recommendation, is another welcome development. This evidence-based clinical recommendation conforms to the definition of clinical practice guidelines, as outlined by Field and Lohr, as "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances." 1 As with most other guidelines that have been produced, there is a clear statement that these recommendations are not a standard of care, requirements or regulations, and that they must be balanced with the practitioner's professional judgment and the individual patient's preferences. This balancing of the evidence (in this case the guideline), professional judgement and the patients' preferences are at the heart of the evidence-based approach.
The scope and purpose of the guideline are clear and there has been widespread consultation with professional groups in both the US and UK, although there is no indication of patient involvement in the development of this recommendation. Patient involvement in guideline development is recommended in the AGREE (Appraisal of Guidelines Research and Evaluation) methodology (www.agreecollaboration.org) and is being used in guidelines under development with bodies such as the Scottish Intercollegiate Guidelines Network (SIGN) and NICE (National Institute for Health and Clinical Excellence) in the UK.
The AGREE appraisal instrument has a number of questions about the rigour of the guideline development and, although it is clear that the approach to the development of this guideline has been systematic, some of the fine detail is missing regarding the search methodology, selection criteria and methods of formulating the recommendation. I am aware that more of this detail was available in the consultation document but it is not in this published version.
The links between the supporting evidence and the recommendations are clearly presented and external review has been undertaken. There is, however, no indication as to whether the guidance will be reviewed and or updated in the future. The availability of an executive summary is helpful, particularly the Table summarising the recommendations.
The article touches briefly on a lack of definition in payment systems for the use of fluoride products to prevent early carious lesions from progressing, but it does not indicate how these or other barriers to adopting the recommendation should be addressed. SIGN and NICE guidelines provide suggestions for auditing and monitoring compliance and perhaps these could be considered in future guidance.
The clinical recommendations are well supported by the evidence and accord well with the two existing evidence-based guidelines on caries prevention available from SIGN. 2, 3 A useful extension to these is that this guidance includes the evidence relating to people over 18 years of age. It is worth noting, however, that these recommendations are based on weaker evidence, largely extrapolated from the data available for the effectiveness of topical fluoride in the younger age groups.
In practice, although the use of both gels and varnishes is effective, ease of use and better patient acceptance of varnish means that my personal preference would be the use of the varnish.
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